Skip to main content
. 2022 Jul 4;12:847793. doi: 10.3389/fonc.2022.847793

Figure 2.

Figure 2

Relationship between KPNA2 levels and tumor immune landscape of TSCC. (A) Relationship between KPNA2 level and the proportion of 22 TIICs in TSCC tissues. (B–E) Box plots show different immune checkpoints between KPNA2 low- and high-expression cases. PD-1 (PDCD1), programmed cell death 1; CYT, cytotoxic activity; TILs, tumor-infiltrating lymphocytes; CTLA-4, cytotoxic T-lymphocyte associated protein 4. *P < 0.05, **P < 0.01 or ***P < 0.001, relative to High group.